Peter J Hougton

10PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 06, 2026
Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors.

Edward Favours, Haiying Tang, Peyton Wong

|Oct 09, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.

Brian Mooney, Gian Luca Negri, Taras Shyp

|Jan 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma.

Terry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva

|Jan 05, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.

Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui

|Sep 26, 2022
Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.

Nicole R Hensch, Kathryn Bondra, Long Wang

|Jul 07, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models.

Fuyang Li, Kathryn M Bondra, Samson Ghilu

Pageof 2

Frequent Collaborators

4 joint publications

Raushan T Kurmasheva

2 joint publications

John M Maris

2 joint publications

Stephen W Erickson

2 joint publications

Edward A Kolb